Exclusive Online Content
BC Platforms Launches End-to-End Solution for Precision Medicine Powered by the Microsoft Genomics Service
BC Platforms, a pioneer in genomic data management and analytics, recently announced it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses…
Vividion Therapeutics Announces Strategic Research Collaboration With Celgene; $101 Million Up-Front Payment
Vividion Therapeutics, Inc., a biotechnology company using revolutionary proteomics and chemistry platforms, recently announced a strategic research collaboration with Celgene Corporation. The multi-year collaboration is focused…
Aduro Announces Development Milestone Achieved Under Merck Collaboration
Aduro Biotech, Inc. recently announced that the company earned a $3-million development milestone payment under its worldwide licensing agreement with Merck (known as MSD outside…
ProJect Pharmaceutics Expands Facilities for Formulation & Lyophilization Process Development
ProJect Pharmaceutics (PJP), specialized in formulation and process development for parenteral drug products, announces that it has extended its safety facilities by laboratories dedicated to…
Fierce Competition Amongst Checkpoint Inhibitor Developers Ahead
Over the next ten years, PD-(L)1 inhibitors will continue to dominate the checkpoint modulators market, says leading data and analytics company GlobalData. PD-(L)1 inhibitors are…
Catalent Completes Multi-Million Expansion at Singapore Clinical Supply Facility
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the completion…
Novo Nordisk Successfully Completes Phase 3a Trial Using Emisphere's Technology
Novo Nordisk recently announced the successful completion of the first Phase 3a trial, PIONEER 1, with oral semaglutide, a once-daily oral formulation of the long-acting…
Biohaven Announces Exclusive License Agreement With Catalent
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company") recently announced it has entered into an exclusive worldwide license agreement with Catalent U.K.…
Lonza Expands Encapsulation & HPAPI Capabilities in North America
Lonza recently announced the expansion of its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in North America. The company…
Majority of Oncology Clinical Trials in China Failed to Meet Enrolment Targets
The majority of oncology clinical trials in China that had a start date between 1 January 2012 and 31 December 2017 failed to meet the…
Biotech Merger & Acquisition Deal Activity Skyrockets in Early 2018
One month into 2018, biotech merger and acquisition (M&A) deal activity has already skyrocketed. Acquisitions from colossal drug makers, Celgene and Sanofi, total more than…
Merck Set to Lead Licensing Deals in 2018
The pharmaceutical industry is highly volatile, with promising lead candidates making or breaking a company’s year. Companies’ financial success is often down to the strategic…
SelfDose™ Patient-Controlled Injector Named as Recipient of Pharmapack Exhibitor Innovation Award
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its SelfDose™ Patient-Controlled Injector was named…
Lupin Receives Innovator Award From BioNJ
Symbiomix, a Lupin Company, received an Innovator Award from BioNJ, New Jersey’s trade association for the biotechnology community. Leadership from the company was on hand…
Syndax Announces Immuno-Oncology Clinical Trial Collaboration With AstraZeneca
Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, recently announced a new clinical collaboration with AstraZeneca to evaluate the…
Evonetix Raises $12.3 Million to Advance Gene Synthesis Platform
Evonetix recently announced it has completed a $12.3-million financing to advance the development of its technology. The financing was co-led by DCVC (Data Collective) of…
Colorcon Transforms the Sugar Coating Process With a New Opadry System
Colorcon Inc. recently announces an exciting process development for sugar coated pharmaceutical tablets with the launch of Opadry® SGR, Rapid Sugar Film Coating System. This…
Sanofi to Acquire Bioverativ for $11.6 Billion
Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which…
Next Breath Announces Injectable Extractable & Leachable Services
Next Breath, a division of AptarGroup, is pleased to announce the extension of their cGMP analytical services to include development services for injectable delivery systems,…
CTI BioPharma to Receive $10-Million Milestone
CTI BioPharma recently announced that it expects to receive a $10-million milestone payment in February 2018 from Teva Pharmaceutical Industries related to the achievement of…
